FDA Approval Highlights: OncLive's February Recap : vimarsan

In case you missed it, below is a recap of all drugs that have been approved by the FDA in February 2024.

Related Keywords

University Of Chicago , Illinois , United States , Tampa , Florida , Boston , Massachusetts , California , Connecticut , Los Angeles , Dana Farber Cancer Institute , New Haven , Davidm Livingston , Daniel Olson , Harriet Kluger , Rachel Kobos , Zeva Wainberg , University Of California , Translational Research , Lowe Center , European Commission , Oncology Research Development , Chen Huang Center , Oncology At Yale Cancer Center , Faculty Development , Division Of Skin , Gastrointestinal Oncology Program , Gastrointestinal Oncology Program At Moffitt Cancer Center , University Of Chicago Medical Center , Harvard Medical School , Belfer Center , Metastatic Pancreatic , Oncology Program , Kwon Kim , Moffitt Cancer Center , Garners Full Approval , Win Approval , Chicago Medical Center , Kate Cushing Professor , Skin Cancer , Internal Medicine , Kidney Cancer , Medical Oncology , Yale Cancer Center , Thoracic Oncology , Applied Cancer Science , Lung Cancers , Harvard Medical , Teclistamab Dosing Snags Approval , Refractory Multiple , Oncology Research , Johnson Innovative Medicine ,